About Shyam Natarajan, Ph.D.
Form D filings for Avenda Health from 2017 to 2024 list Shyam Natarajan, Ph.D. as chief executive officer and director.
Shyam Natarajan, Ph.D. first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Shyam Natarajan, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Shyam Natarajan, Ph.D. works with at each company, as listed on that company's latest Form D.
Avenda Health, Inc. · Form D/A, Jan 18, 2024
RD
Ronald Sugar, Ph.D.
Director
MK
Michael Klein
Director
LD
Leonard Marks, M.D.
Director
BD
Brittany Pusey, Ph.D.
Executive officer